(function(e){function t(t){for(var n,s,o=t[0],l=t[1],c=t[2],u=0,E=[];u<o.length;u++)s=o[u],Object.prototype.hasOwnProperty.call(r,s)&&r[s]&&E.push(r[s][0]),r[s]=0;for(n in l)Object.prototype.hasOwnProperty.call(l,n)&&(e[n]=l[n]);d&&d(t);while(E.length)E.shift()();return i.push.apply(i,c||[]),a()}function a(){for(var e,t=0;t<i.length;t++){for(var a=i[t],n=!0,o=1;o<a.length;o++){var l=a[o];0!==r[l]&&(n=!1)}n&&(i.splice(t--,1),e=s(s.s=a[0]))}return e}var n={},r={app:0},i=[];function s(t){if(n[t])return n[t].exports;var a=n[t]={i:t,l:!1,exports:{}};return e[t].call(a.exports,a,a.exports,s),a.l=!0,a.exports}s.m=e,s.c=n,s.d=function(e,t,a){s.o(e,t)||Object.defineProperty(e,t,{enumerable:!0,get:a})},s.r=function(e){"undefined"!==typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},s.t=function(e,t){if(1&t&&(e=s(e)),8&t)return e;if(4&t&&"object"===typeof e&&e&&e.__esModule)return e;var a=Object.create(null);if(s.r(a),Object.defineProperty(a,"default",{enumerable:!0,value:e}),2&t&&"string"!=typeof e)for(var n in e)s.d(a,n,function(t){return e[t]}.bind(null,n));return a},s.n=function(e){var t=e&&e.__esModule?function(){return e["default"]}:function(){return e};return s.d(t,"a",t),t},s.o=function(e,t){return Object.prototype.hasOwnProperty.call(e,t)},s.p="/";var o=window["webpackJsonp"]=window["webpackJsonp"]||[],l=o.push.bind(o);o.push=t,o=o.slice();for(var c=0;c<o.length;c++)t(o[c]);var d=l;i.push([0,"chunk-vendors"]),a()})({0:function(e,t,a){e.exports=a("56d7")},"034f":function(e,t,a){"use strict";a("85ec")},"56d7":function(e,t,a){"use strict";a.r(t);a("e260"),a("e6cf"),a("cca6"),a("a79d");var n=a("2b0e"),r=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("div",{staticStyle:{"max-width":"500px",margin:"0 auto"},attrs:{id:"app mx-auto"}},[1===e.page?a("div",[a("Header"),a("div",{staticClass:"m-3",staticStyle:{color:"#000","padding-top":"80px",display:"flex","justify-content":"space-between"}},[a("div",[e._v("All Users")]),a("div",{class:e.enableSelect?"is-selecting":"not-selecting",on:{click:function(t){e.enableSelect=!e.enableSelect}}},[e._v(" Select ")])]),a("div",[a("b-form-checkbox-group",{attrs:{id:"checkbox-group-2",name:"flavour-2"},model:{value:e.selectedUsers,callback:function(t){e.selectedUsers=t},expression:"selectedUsers"}},e._l(e.users,(function(t,n){return a("div",{key:"user_"+n,staticClass:"user-in-list",on:{click:function(a){return e.gotoPage(t)}}},[a("div",{staticStyle:{flex:"2"}},[a("div",[e._v(e._s(t.name))]),a("div",[e._v(e._s(t.diseases))])]),a("div",{staticStyle:{flex:"1"}},[e._v(" "+e._s(t.age)+" "+e._s(t.gender)+" ")]),a("div",{staticStyle:{width:"30px"}},[e.enableSelect?a("div",[a("b-form-checkbox",{attrs:{value:t.id},on:{click:e.selectUser}})],1):e._e()])])})),0)],1),e.enableSelect&&e.selectedUsers.length>0?a("Footer"):e._e()],1):2===e.page?a("div",[a("HeaderPage2",{attrs:{user:e.viewUser},on:{gotoPage:e.goBackToPage}}),a("div",{staticStyle:{color:"#000","padding-top":"80px",display:"flex","flex-wrap":"wrap"}},e._l(e.filters,(function(t,n){return a("div",{key:"fil_"+n,staticClass:"filter"},[e._v(" "+e._s(t)+" ")])})),0),a("div",{staticStyle:{padding:"20px 10px"}},[e.viewUser.medication?a("div",[a("h4",[e._v("Medication")]),e._l(e.viewUser.medication,(function(t,n){return a("div",{key:"med_"+n},[e._v(" "+e._s(t.StartDate)+" "+e._s(t.EndDate)+" "+e._s(t.Medicine)+" ")])}))],2):e._e(),e.viewUser.labs?a("div",[a("h4",[e._v("Labs")]),e._l(e.viewUser.labs,(function(t,n){return a("div",{key:"lab_"+n,staticClass:"lab-info"},[a("div",{staticClass:"med-labname"},[e._v(e._s(t.labName))]),a("div",[e._v(e._s(t.labData))])])}))],2):e._e()])],1):e._e()])},i=[],s=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"nav-shadow",staticStyle:{"background-color":"#fff !important"},attrs:{type:"light",fixed:"top"}},[a("Sidebar"),a("b-form-input",{staticClass:"m-1",attrs:{placeholder:"Search"}}),a("b-button",{staticClass:"my-2 my-sm-0",attrs:{variant:"light",type:"submit"}})],1)},o=[],l=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("div",[a("b-button",{directives:[{name:"b-toggle",rawName:"v-b-toggle.sidebar-variant",modifiers:{"sidebar-variant":!0}}],staticClass:"m-1",staticStyle:{"font-size":"18px",border:"none","padding-top":"10px"},attrs:{variant:"outline-secondary"}},[a("b-icon",{attrs:{icon:"list"}})],1),a("b-sidebar",{attrs:{id:"sidebar-variant",title:"Sidebar","bg-variant":"light","text-variant":"dark",shadow:""}},[a("div",{staticClass:"px-3 py-2"},[a("p")])])],1)},c=[],d=a("2877"),u={},E=Object(d["a"])(u,l,c,!1,null,null,null),b=E.exports,R={name:"Header",components:{Sidebar:b}},m=R,p=Object(d["a"])(m,s,o,!1,null,null,null),f=p.exports,g=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"nav-shadow",staticStyle:{"background-color":"#fff !important"},attrs:{type:"light",fixed:"top"}},[a("b-button",{staticClass:"my-2 my-sm-0 mr-2",attrs:{variant:"transparent"},on:{click:e.back}},[a("BackIcon")],1),e._v(" "+e._s(e.user.name)+" ")],1)},v=[],D=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("svg",{attrs:{width:"18",height:"12",viewBox:"0 0 18 12",fill:"none",xmlns:"http://www.w3.org/2000/svg"}},[a("path",{attrs:{d:"M18 5H3.83L7.41 1.41L6 0L0 6L6 12L7.41 10.59L3.83 7H18V5Z",fill:"#C6C2C2"}})])},B=[],H={},S=H,P=Object(d["a"])(S,D,B,!1,null,null,null),x=P.exports,h={name:"HeaderPage2",props:["user"],components:{BackIcon:x},methods:{back:function(){this.$emit("gotoPage",1)}}},w=h,C=Object(d["a"])(w,g,v,!1,null,null,null),M=C.exports,_=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"nav-footer-shadow",staticStyle:{display:"flex","justify-content":"center"},attrs:{shadow:"",variant:"light",type:"light",fixed:"bottom"}},[a("b-button",{attrs:{variant:"light"}},[a("AppleUploadIcon"),a("span",{staticStyle:{"margin-left":"10px"}},[e._v("View in Sheets")])],1)],1)},k=[],y=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("svg",{attrs:{width:"19",height:"18",viewBox:"0 0 19 18",fill:"none",xmlns:"http://www.w3.org/2000/svg","xmlns:xlink":"http://www.w3.org/1999/xlink"}},[a("rect",{attrs:{y:"18",width:"18",height:"19",transform:"rotate(-90 0 18)",fill:"url(#pattern0)"}}),a("defs",[a("pattern",{attrs:{id:"pattern0",patternContentUnits:"objectBoundingBox",width:"1",height:"1"}},[a("use",{attrs:{"xlink:href":"#image0",transform:"translate(0 0.0263158) scale(0.0416667 0.0394737)"}})]),a("image",{attrs:{id:"image0",width:"24",height:"24","xlink:href":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAAs0lEQVRIS+2VwQ2DQAwEhx9FkNRDJamBH3zTQtII9ZBCQJYOyVLMsSfBAwl+gL2zWMe64uSrOlmfUsAA1ECnGisBmHifhN8qRAV48dW8BFEAkbgMUQB+3HO6kfuiwhb4Ag38HYItgD3/AS9g9I4iwAQ8NpzmANZikOceIDeG4nfRFxSLJMdh3w3YPcL3iK43otwaOOQ/OATgs0hdXGudlEWWph8XeCpETlNVUKqTF4ekFhQtWP41GUyN2LsAAAAASUVORK5CYII="}})])])},A=[],U={},N=U,O=Object(d["a"])(N,y,A,!1,null,null,null),z=O.exports,G={components:{AppleUploadIcon:z}},T=G,j=Object(d["a"])(T,_,k,!1,null,null,null),F=j.exports,q={name:"App",components:{Header:f,Footer:F,HeaderPage2:M},data:function(){return{page:1,enableSelect:!1,viewUser:"",users:[{id:1,name:"Tania Sethi",age:52,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:2,name:"Marilyn Harms",age:54,gender:"M",diseases:"Cholangiocarcinoma",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:3,name:"Sandra Mitchell",age:49,gender:"F",diseases:"Cholangiocarcinoma",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]}],filters:["medication","labs","diagnosis","procedure","vitals","allergies"],selectedUsers:[]}},methods:{selectUser:function(e){console.log(e),alert("user selected")},gotoPage:function(e){0!==this.selectedUsers.length||this.enableSelect||(this.viewUser=e,this.page=2)},goBackToPage:function(e){this.page=e}}},I=q,L=(a("034f"),Object(d["a"])(I,r,i,!1,null,null,null)),Q=L.exports,V=a("5f5b"),$=a("b1e0"),Y=(a("f9e3"),a("2dd8"),a("2f62"));n["default"].use(Y["a"]);var J=new Y["a"].Store({state:{},mutations:{},actions:{},modules:{}});n["default"].config.productionTip=!1,n["default"].use(V["a"]),n["default"].use($["a"]),new n["default"]({store:J,render:function(e){return e(Q)}}).$mount("#app")},"85ec":function(e,t,a){}});
//# sourceMappingURL=app.0382ef74.js.map